{"title":"糖尿病内皮祖细胞功能障碍:风险分层和治疗的新目标?","authors":"A. Berezin, A. Berezin","doi":"10.12988/bmgt.2019.915","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":150008,"journal":{"name":"Biological Markers and Guided Therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endothelial progenitor cell dysfunction in diabetes mellitus: new target for risk stratification and therapies?\",\"authors\":\"A. Berezin, A. Berezin\",\"doi\":\"10.12988/bmgt.2019.915\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":150008,\"journal\":{\"name\":\"Biological Markers and Guided Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biological Markers and Guided Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12988/bmgt.2019.915\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological Markers and Guided Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12988/bmgt.2019.915","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}